Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-22T18:25:49.992Z Has data issue: false hasContentIssue false

21 - Methamphetamine

from Part VI - Substance Abuse and Medications

Published online by Cambridge University Press:  06 January 2010

By
Liz Jacob  and
Willam Haining III
Edited by
Daryl Fujii  and
Iqbal Ahmed
Liz Jacob
Affiliation:
University of Hawaii
Willam Haining III
Affiliation:
University of Hawaii
Daryl Fujii
Affiliation:
University of Hawaii, Manoa
Iqbal Ahmed
Affiliation:
University of Hawaii, Manoa
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Spectrum of Psychotic Disorders
Neurobiology, Etiology and Pathogenesis
 , pp. 392 - 405
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abi-Dargham, A. (2004). Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology, 7, S1–5.Google Scholar
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association.
Baumeister, A. A. & Francis, J. L. (2002). Historical development of the dopamine hypothesis of schizophrenia. Journal of the History of the Neurosciences, 11, 265–77.Google Scholar
Boutros, N. N. & Bowers, M. B. (1996). Chronic substance-induced psychotic disorders: State of the literature. Journal of Neuropsychiatry and Clinical Neuroscience, 8, 262–9.Google Scholar
Cass, W. A. & Manning, M. W. (1999). Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. Journal of Neuroscience, 19, 7653–60.Google Scholar
Caton, C. L., Drake, R. E., Hasin, D. S., et al. (2005). Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry, 62, 137–45.Google Scholar
Chang, L., Ernst, T., Speck, O., et al. (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatric Research Neuroimaging, 114, 65–79.Google Scholar
Chen, C. K., Lin, S. K., Sham, P. C., et al. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine, 33, 1407–14.Google Scholar
Community Epidemiology Work Group (2003). Epidemiologic Trends in Drug Abuse, Advance Report (NIH Publication No. 04–5363). Washington, DC: US Government Printing Office.
Drug Abuse Warning Network (2004, July). Amphetamine and Methamphetamine Emergency Department Visits, 1995–2002 (NIH Publication No. 02–4210). Washington, DC: US Government Printing Office.
Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study, Neurology, 54, 1344–9.Google Scholar
Flaum, M. & Schultz, S. K. (1996). When does amphetamine-induced psychosis become schizophrenia?American Journal of Psychiatry, 153, 812–15.Google Scholar
Fujii, D. (2002). Risk factors for treatment-resistive methamphetamine psychosis. Journal of Neuropsychiatry and Clinical Neurosciences, 14, 239–40.Google Scholar
Gonzalez, R., Rippeth, J. D., Carey, C. L., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76, 181–90.Google Scholar
Graham, A. W., Schultz, T. K., Mayo-Smith, M. F., Ries, R. K., Wilford, B. B. (eds.) (2003). Principles of Addiction Medicine, 3rd edn. Chevy Chase: American Society of Addiction Medicine.
Grant, I., Gonzalez, R., Carey, C., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9, 679–89.Google Scholar
Harvey, D. C., Lacan, G., Tanious, S. P., & Melega, W. P. (2000). Recovery from methamphetamine-induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Research, 871, 259–70.Google Scholar
Iwanami, A., Sugiyama, A., Kuroki, N., et al. (1994). Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. Acta Psychiatrica Scandinavica, 89, 428–32.Google Scholar
Kalechstein, A. D., Newton, T. E., Longshore, D., et al. (2000). Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 480–84.Google Scholar
Kalechstein, A. D., Newton, T. F., & Green, M. (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 215–20.Google Scholar
Ling, W. & Shoptaw, S. (1997). Integration of research in pharmacotherapy for substance abuse: Where are we? Where are we going?Journal of Addictive Disease, 16, 83–102.Google Scholar
Lowinson, J. H., Ruiz, P., Millman, R. B., Langrod, J. G. (eds.) (2005). Substance Abuse: A Comprehensive Textbook, Philadelphia, PA: Lippincott Williams & Wilkins.
Mikami, T., Naruse, N., Fukura, Y., et al. (2003). Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements. Psychiatry and Clinical Neurosciences, 57, 433–40.Google Scholar
National Drug Intelligence Center (2005). National Drug Assessment Report (DOJ Product No. 2005–Q0317–005). Washington, DC: Government Printing Office.
National Institute on Drug Abuse (2002). Research Report Series, Methamphetamine Abuse and Addiction (NIH Publication Number 02–4210). Washington, DC: Government Printing Office.
Nordahl, T. E., Salo, R., & Leamon, M. (2003). Neurocognitive effects of chronic methamphetamine use on neurotransmitters and cognition: A review. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 317–25.Google Scholar
Paulus, M., Hozack, N., Frank, L., Brown, G. G., & Schuckit, M. A. (2003). Decision by methamphetamine-dependent subjects is associated with error-rate independent decrease in prefrontal and parietal activation. Biological Psychiatry, 53, 65–74.Google Scholar
Rawson, R. A., Gonzales, R., & Brethren, P. (2002). Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment, 23, 145–50.Google Scholar
Rippeth, J. D., Heaton, R. K., Carey, C. L., et al. (2004). Methamphetamine dependence increases risk of neurocognitive impairment in HIV infected persons. Journal of International Neurocognitive Society, 10, 1–14.Google Scholar
Salo, R., Nordahl, T. E., Possin, K., et al. (2002). Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatric Research, 111, 65–74.Google Scholar
Sato, M., Numachi, Y., & Hamamura, T. (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophrenia Bulletin, 18, 115–22.Google Scholar
Seiden, L. S. & Sabol, K. E. (1996). Methamphetamine and methylenedioxymethamphetamine neurotoxicity: Possible mechanisms of cell destruction. Abstract. NIDAResearch Monographs, 163, 251–76.Google Scholar
Sekine, Y., Iyo, M., Ouchi, Y., et al. (2001). Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry, 158, 1206–14.Google Scholar
Shaner, A., Roberts, L. J., Eckman, T. A., et al. (1998). Psychiatric Services, 49, 684–90.
Sim, T., Simon, S. L., Domier, C. P., et al. (2002). Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology. Journal of Addictive Diseases, 21, 75–89.Google Scholar
Simon, S. L., Domier, C., Carnell, J., et al. (2000). Cognitive impairment in individuals currently using methamphetamine. American Journal on Addictions, 9, 222–31.Google Scholar
Srisurapanont, M., Ali, R., Marsden, J., et al. (2003). Psychotic symptoms in methamphetamine psychotic inpatients. Journal of Neuropsychopharmacology, 6, 347–52.Google Scholar
Tomiyama, G. (1990). Chronic schizophrenia-like states in methamphetamine psychosis. Japanese Journal of Psychiatry, 44, 531–9.Google Scholar
Trites, R. L., Suh, M., Offord, D., Nieman, G., & Preston, D. (1976). Neuropsychologic psychosocial antecedents and chronic effects of prolonged use of solvents and methamphetamine. Psychiatric Journal of the University of Ottawa, 1(Suppl. 2), 14–20.Google Scholar
United States Drug Enforcement Agency (2005, February). State Factsheets: Hawaii 2005. Washington, DC: Government Printing Office.
Volkow, N. D., Chang, L., Wang, , , G., et al. (2001a). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience, 21, 9414–18.Google Scholar
Volkow, N. D., Chang, L., Wang, , , G., et al. (2001b). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158, 377–82.Google Scholar
Yeh, H. S., Lee, Y. C., Sun, H. J., & Wan, S. R. (2001). Six months follow-up of patients with methamphetamine psychosis. Chinese Medical Journal, 64, 388–94.Google Scholar
Yui, K., Goto, K., Ikemoto, S., et al. (1999). Neurobiologic basis of relapse prediction in stimulant-induced psychosis and schizophrenia: The role of sensitization. Molecular Psychiatry, 4, 512–23.Google Scholar
Yui, K., Goto, K., Ikemoto, S., et al. (2001). Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis. Drug and Alcohol Dependence, 64, 133–42.Google Scholar
Zweben, J. E., Cohen, J. B., Christian, D., et al. (2004). Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13, 181–90.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×